文献速递神经肿瘤

KCNAB2表达在调节生长激素型垂体腺瘤激素分泌中的作用

Role of KCNAB2 expression in modulating hormone secretion in somatotroph pituitary adenoma.
PubMed 文献 · J Neurosurg · 2020-02-28

该研究基于人垂体腺瘤DNA甲基化数据,在GH3大鼠生长激素细胞系中过表达或敲低Kcnab2,并用奎尼丁处理,发现Kcnab2表达与GH分泌成正比,奎尼丁(≥50 µM)剂量依赖性地减少GH和催乳素分泌,提示KCNAB2和奎尼丁可能是肢端肥大症治疗的潜在靶点与药物候选。

要点

  • Kcnab2部分敲低使GH转录本和分泌减少,过表达则使GH转录本和分泌增多。
  • 奎尼丁(≥50 µM)剂量依赖性地减少GH3细胞的GH和催乳素分泌(p ≤ 0.05)。
  • 生长激素细胞系的GH分泌部分依赖KCNAB2基因表达,体外可被奎尼丁减弱。

核心结论

  • 生长激素细胞系的GH分泌部分依赖KCNAB2基因表达,并可能在体外被奎尼丁减弱。
  • 结果提示KCNAB2和奎尼丁可能是肢端肥大症临床治疗开发中值得考虑的潜在新靶点和药物候选。

研究设计与样本

  • 重新分析既往RNA-seq数据,比较人无功能垂体腺瘤与GH分泌型垂体腺瘤中KCNAB2表达水平。
  • 在GH3大鼠乳腺生长激素细胞系中用质粒转染过表达Kcnab2、用shRNA敲低Kcnab2,并经qPCR确认。
  • 细胞接种后24小时收集培养上清,用ELISA测定GH浓度。
  • 另以梯度剂量奎尼丁处理GH3细胞,处理48小时后用荧光免疫分析法测定上清GH和催乳素浓度。

主要发现

  • GH3细胞中Kcnab2转录水平调控导致GH mRNA表达和GH肽分泌成比例变化,经qPCR和ELISA确认。
  • 与对照相比,Kcnab2部分敲低与GH RNA转录本减少和GH分泌减少相关。
  • 与对照相比,Kcnab2表达增强与GH转录本和分泌增多相关。
  • 奎尼丁(≥50 µM)剂量依赖性地减少GH和催乳素分泌(p ≤ 0.05)。

临床怎么用

  • 原文结论为体外结果,作者认为KCNAB2和奎尼丁是肢端肥大症临床治疗开发中值得考虑的潜在新靶点和药物候选。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Prior profiling of the human pituitary adenoma (PA) DNA methylome showed the potassium channel subunit-encoding gene KCNAB2 to be highly differentially methylated between nonfunctional PAs (NFPAs) and growth hormone (GH)-secreting PAs, with greater KCNAB2 methylation detected in secretory PAs. KCNAB2 encodes an aldo-keto reductase that, among other things, negatively regulates members of the voltage-gated potassium channel (Kv) family. In this study, the authors aimed to determine whether modulation of Kcnab2 expression would alter GH secretion in the GH3 mammosomatotroph rat cell line. In addition, they examined whether dosing GH3 cells with the antiarrhythmic drug quinidine, a known inhibitor of Kv and voltage-gated sodium channels, would affect hormonal secretion. METHODS: Previously generated RNA-seq data were reanalyzed to compare KCNAB2 expression levels in human NFPAs and GH-secreting PAs. Kcnab2 was overexpressed in GH3 cells using plasmid transfection and knocked down using shRNA, with confirmation by quantitative polymerase chain reaction (qPCR). GH concentrations in cell culture supernatants collected 24 hours after cell seeding were measured using enzyme-linked immunosorbent assay (ELISA). Separately, quinidine was administered to GH3 cells at graduated doses. GH and prolactin concentrations in supernatants collected 48 hours after quinidine treatment were measured by fluorometric immunoassay. RESULTS: Modulation of expression at the transcript level in GH3 cells resulted in proportionate changes in the expression of GH mRNA and secretion of GH peptide, as confirmed by qPCR and ELISA. Specifically, partial knockdown of Kcnab2 was associated with fewer GH RNA transcripts and less GH secretion compared with controls, while augmentation of Kcnab2 expression was associated with more GH transcripts and secretion than the controls. Administration of quinidine (≥ 50 µM) reduced both GH and prolactin secretion in a dose-dependent fashion (p ≤ 0.05). CONCLUSIONS: GH secretion in a somatotroph cell line is partially dependent on KCNAB2 gene expression and may be mitigated in vitro by quinidine. These results collectively suggest a potential new target and pharmacological candidate to be considered in the development of clinical therapeutics for acromegaly.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ashton C, Rhie SK, Carmichael JD, et al. Role of KCNAB2 expression in modulating hormone secretion in somatotroph pituitary adenoma. J Neurosurg. 2020. PMID: 32109873. doi:10.3171/2019.12.JNS192435

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。